| Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients J Mallard, E Hucteau, AL Charles, L Bender, C Baeza, M Pélissie, ... Journal of cachexia, sarcopenia and muscle 13 (3), 1896-1907, 2022 | 23 | 2022 |
| Early skeletal muscle deconditioning and reduced exercise capacity during (neo) adjuvant chemotherapy in patients with breast cancer J Mallard, E Hucteau, R Schott, P Trensz, C Pflumio, M Kalish‐Weindling, ... Cancer 129 (2), 215-225, 2023 | 9 | 2023 |
| Development of skeletal muscle atrophy and intermuscular adipose tissue in patients with early breast cancer treated with chemotherapy J Mallard, E Hucteau, L Bender, A Charlot, L Debrut, C Pflumio, P Trensz, ... American Journal of Physiology-Cell Physiology 323 (4), C1325-C1332, 2022 | 5 | 2022 |
| Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy E Hucteau, J Mallard, X Pivot, R Schott, C Pflumio, P Trensz, F Favret, ... European Journal of Applied Physiology 123 (7), 1567-1581, 2023 | 4 | 2023 |
| FDG PET to diagnose neurolymphomatosis in a case of triple-Hit B-Cell lymphoma C Bund, C Heimburger, P Trensz, C Fohrer, S Kremer, IJ Namer Clinical Nuclear Medicine 42 (6), 458-460, 2017 | 4 | 2017 |
| Impact of the app-based and nurse-led supportive care program AKO@ dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a … V Gaillard, A Lhuillier, C Bigot, L Pierard, P Trensz, M Burgy, C Schuster, ... Supportive Care in Cancer 30 (8), 6583-6591, 2022 | 3* | 2022 |
| A propensity score–weighted study comparing a two-versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer H Bischoff, C Bigot, F Moinard-Butot, C Pflumio, C Fischbach, M Kalish, ... Breast Cancer Research and Treatment 198 (1), 23-29, 2023 | 2 | 2023 |
| The hard road to patient-centered care: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer? P Trensz, L Calvel, JE Kurtz Annals of Oncology 29 (7), 1601, 2018 | 2 | 2018 |
| A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients J Mallard, E Hucteau, L Bender, F Moinard‐Butot, E Rochelle, ... Journal of Cachexia, Sarcopenia and Muscle 15 (1), 292-305, 2024 | 1 | 2024 |
| COVID-19 et modification des aides à domicile: étude prospective auprès de 100 patients suivis en CLCC M Despinasse, A Schohn, A Bimboes, P Trensz, F Sirlin, P Chiappa, ... Bulletin du Cancer 109 (4), 396-408, 2022 | 1 | 2022 |
| Metastatic cancer patients hospitalized at initial diagnosis: when does rescue systemic therapy make sense? C Vercueil, R Varnier, R Seban, L Ciaptacz, J Pavillet, C Fraisse, ... | | 2024 |
| Can health forums dedicated to breast cancer be useful to caregivers? Analysis of initial messages on the National League against Cancer forum over a one-year period H Burgué, P Trensz, C Mathelin, A Schohn Gynecologie, Obstetrique, Fertilite & Senologie, S2468-7189 (24) 00042, 2024 | | 2024 |
| Les forums de discussion dédiés au cancer du sein peuvent-ils être utiles aux soignants? Analyse des messages initiaux du forum de la Ligue Nationale Contre le Cancer pendant … H Burgué, P Trensz, C Mathelin, A Schohn Gynécologie Obstétrique Fertilité & Sénologie, 2024 | | 2024 |
| Primary resistance to ALK inhibitors in KLC1/ALK-rearranged pleural metastatic lung adenocarcinoma: a case report L Siblini, R Schott, P Trensz, E Pencreach, L Bender Translational Lung Cancer Research 12 (11), 2342, 2023 | | 2023 |
| 2054P Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS-A national, prospective study C Vercueil, R Varnier, R Seban, L CIaptacz, J Pavillet, C Fraisse, ... Annals of Oncology 34, S1086, 2023 | | 2023 |
| Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer L Bender, C Pflumio, P Trensz, L Pierard, M Kalish, C Fischbach, T Petit Cancer Treatment and Research Communications 36, 100738, 2023 | | 2023 |
| Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the … S Martin, C Pflumio, P Trensz, F Schaff-Wendling, M Kalish-Weindling, ... Clinical Breast Cancer 23 (1), 32-37, 2023 | | 2023 |
| Development of skeletal muscle atrophy and intermuscular adipose tissue in early breast cancer patients treated with chemotherapy. J Mallard, E Hucteau, L Bender, A Charlot, L Debrut, C Pflumio, P Trensz, ... American Journal of physiology. Cell Physiology, 2022 | | 2022 |
| Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the … S Martin, C Pflumio, P Trensz, F Schaff-Wendling, M Kalish, C Fischbach, ... CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the … S Martin, C Pflumio, P Trensz, F Schaff-Wendling, M Kalish, C Fischbach, ... Cancer Research 82 (4_Supplement), P1-17-07-P1-17-07, 2022 | | 2022 |
